Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) EBT Margin (2018 - 2025)

Dna X (SONM) has disclosed EBT Margin for 8 consecutive years, with 28.76% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT Margin fell 1282.0% year-over-year to 28.76%, compared with a TTM value of 50.49% through Sep 2025, down 2756.0%, and an annual FY2024 reading of 58.42%, down 5872.0% over the prior year.
  • EBT Margin was 28.76% for Q3 2025 at Dna X, up from 65.56% in the prior quarter.
  • Across five years, EBT Margin topped out at 53.18% in Q4 2022 and bottomed at 98.5% in Q4 2024.
  • Average EBT Margin over 5 years is 31.86%, with a median of 28.76% recorded in 2025.
  • The sharpest move saw EBT Margin skyrocketed 12714bps in 2022, then crashed -8912bps in 2024.
  • Year by year, EBT Margin stood at 73.96% in 2021, then surged by 172bps to 53.18% in 2022, then crashed by -118bps to 9.38% in 2023, then crashed by -950bps to 98.5% in 2024, then skyrocketed by 71bps to 28.76% in 2025.
  • Business Quant data shows EBT Margin for SONM at 28.76% in Q3 2025, 65.56% in Q2 2025, and 3.53% in Q1 2025.